captopril has been researched along with Alloxan Diabetes in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (8.16) | 18.7374 |
1990's | 32 (32.65) | 18.2507 |
2000's | 36 (36.73) | 29.6817 |
2010's | 16 (16.33) | 24.3611 |
2020's | 6 (6.12) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Gao, X; Hu, C; Jiang, Z; Liu, K | 1 |
Alizadeh-Fanalou, S; Chamani, E; Ebadi, Z; Fadaei, R; Fallah, S; Ghaffari, T; Moradi, N; Yarahmadi, S | 1 |
Carvalho, VF; Chaves, ADS; Insuela, DBR; Magalhães, NS; Martins, MA; Silva, PMRE | 1 |
Balochnejadmojarrad, T; Chamani, E; Ebadi, Z; Fadaei, R; Fallah, S; Kazemi Fard, T; Moradi, N | 1 |
Jesson, MI; Nikolic-Paterson, DJ; Pullen, N; Schlerman, FJ; Tesch, GH | 1 |
Abd El-Latif, HA; El-Yamany, MF; Georgy, GS; Youssef, MM | 1 |
Abo-Saif, AA; Kozman, MR; Messiha, BAS; Mizar, SMM | 1 |
Chu, S; Li, H; Liu, D; Liu, X; Qu, X; Shuai, Y; Zhang, X; Zhao, H | 1 |
Abadir, P; Ansari, A; Berger, A; Beselman, A; Budman, J; Faghih, M; Fedarko, N; Harmon, J; Hosseini, S; Inagami, T; Keenahan, K; Lay, F; Marti, G; Rini, D; Smith, B; Tian, J; Vuong, D; Walston, J | 1 |
Dong, LY; Jin, KK; Qiu, XX; Yao, LP; Zhao, J | 1 |
Mohebbati, R; Niazmand, S; Paseban, M; Sahebkar, A; Sathyapalan, T | 1 |
Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y | 1 |
Akhtar, S; Al-Rashdan, I; Babiker, F; Benter, IF; Yousif, M | 1 |
Awad, AS; Cooper, TK; Gao, T; Gvritishvili, A; Tombran-Tink, J; You, H | 1 |
Abd Allah, ES; Gomaa, AM | 1 |
Davis, G; Harrison, JC; Sammut, IA; Walker, RJ; Yao, Y | 1 |
Jakovljevic, VL; Nikolic, T; Ristic, D; Ristic, P; Srejovic, I; Stojic, I; Zivkovic, V | 1 |
Li, XL; Sha, NN; Shi, Q; Shu, B; Wang, XL; Wang, YJ; Wong, MS; Xiao, HH; Zhang, Y; Zhao, YJ | 1 |
Ku, SK; Lee, HS | 1 |
Lu, J; Sun, L; Yu, XJ; Zang, WJ; Zhang, CH | 1 |
Al-Maghrebi, M; Benter, IF; Diz, DI | 1 |
Bogdanski, P; Czaplicka, E; Jablecka, A; Krauss, H; Olszewski, J; Smolarek, I | 1 |
Chaves, MM; Chianca-Júnior, D; Costa, DC; Granato de Faria, K; Lima, WG; Pádua, Bda C; Pedrosa, ML; Rodrigues de Araujo, G; Rossoni, JV; Silva, ME; Souza, AA | 1 |
Chu, L; Guan, SJ; Guo, QY; Ji, ES; Liang, F; Ma, ZH; Wang, JY; Weiss, JW; Wu, YL; Zhang, JP | 1 |
Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
Al-Mulhim, AS; Fouad, AA; Jresat, I; Morsy, MA | 1 |
Allen, TJ; Burrell, LM; Cao, Z; Cooper, ME; Davis, BJ; Lassila, M | 1 |
Akalin, S; Akoğlu, E; Ersöz, O; Haklar, G; Küçükkaya, B; Yavuz, D | 1 |
Gao, L; Kern, TS; Widness, M; Xi, X; Zhang, JZ | 1 |
Abiko, A; Abiko, T; Bursell, SE; Clermont, AC; Feener, EP; Horio, N; Shoelson, BD | 1 |
Kanaki, T; Matsuda, M; Naitoh, T; Tsuruzoe, N; Yotsumoto, T | 1 |
Ekberg, K; Isaksson, B; Jacobson, SH; Johansson, BL; Samnegård, B; Sjöquist, M; Wahren, J | 1 |
Ghini, B; Lehfeld, LS; Lopes de Faria, JB; Silveira, LA | 1 |
Chen, G; Huang, HB; Li, LT; Liang, JX; Lin, LX; Lin, M; Lin, QM; Wen, JP; Yao, J; Zhang, FL; Zhuang, WT | 1 |
Xie, XW; Zhao, P | 1 |
Leehey, DJ; Singh, AK; Singh, R | 1 |
Godes, M; Hocher, B; Neumayer, HH; Richter, CM; Simon, K; Thöne-Reinke, C; Thormählen, D | 1 |
Ibrahim, MA; Kanzaki, T; Satoh, N; Ueda, S; Yamagata, S | 1 |
Cool, DR; Elased, KM; Morris, M | 1 |
Amazonas, RB; Lopes de Faria, JB | 1 |
Danser, AH; Krop, M; van Esch, JH | 1 |
Bell, TD; Brands, MW; Fleming, C; Janardhanan, R; Rojas, M; Springfield, V; Sturgis, LC | 1 |
Cai, H; Oak, JH | 1 |
Arikawa, E; Harris, RA; He, Z; Isshiki, K; King, GL; Luptak, I; Ma, RC; Maeno, Y; Patti, ME; Tian, R; Weir, GC; Yasuda, Y; Zammit, VA | 1 |
Gao, YY; Lu, Q; Pan, YM; Wang, JY; Yin, XX | 1 |
Akyuz, F; Temel, HE | 1 |
Gao, L; Kern, TS; Xi, X; Zhang, JZ | 1 |
Huang, Z; Jansson, L; Sjöholm, A | 1 |
Abe, K; Fu, LP; Kanazawa, M; Kohzuki, M; Obara, K; Saito, T; Yasujima, M; Yoshida, K | 1 |
Barbee, RW; Conrad, K; Maymind, M; Zimmerman, R | 1 |
Nickels, D; Poth, M; Schwab, N | 1 |
Abe, K; Hiwatari, M; Kanazawa, M; Kohzuki, M; Omata, K; Sato, T; Watanabe, H; Yasujima, M; Yoshida, K | 1 |
Chen, GY; Chen, LH | 1 |
Cosio, FG; Hajinazarian, M; Mahan, JD; Nahman, NS | 1 |
Liu, Z | 1 |
Kato, Y; Nara, Y; Sato, T; Yamori, Y | 1 |
Candy, G; Norton, GR; Woodiwiss, AJ | 1 |
Bensaoula, T; Ottlecz, A | 2 |
Abe, K; Kanazawa, M; Kohzuki, M; Yasujima, M; Yoshida, K | 1 |
Geng, J; Lu, J; Pan, C | 1 |
Chakir, M; D'Orléans-Juste, P; Plante, GE | 1 |
Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
Abe, K; Kanazawa, M; Kohzuki, M; Liu, PF; Obara, K; Saito, T; Sato, T; Yasujima, M; Yoshida, K | 1 |
Fukui, M; Shou, I; Tang, Z; Tomino, Y; Wang, LN | 1 |
Bartoli, E; Griffin, CA; Schambelan, M; Sechi, LA; Valentin, JP; Zingaro, L | 1 |
Naitoh, T; Shikada, K; Tanaka, S; Yotsumoto, T | 1 |
Beyer, KH; Follansbee, MH; Griffith, JW; Vesell, ES | 1 |
Beyer, KH; Follansbee, MH; Vesell, ES | 1 |
Flyvbjerg, A; Grønbaek, H; Lancranjan, I; Orskov, H; Osterby, R; Vogel, I | 1 |
Kedziora-Kornatowska, K; Luciak, M | 1 |
Allen, TJ; Burrell, LM; Cooper, ME; Johnston, CI; Rockell, MD; Tikkanen, I; Tikkanen, T | 1 |
Ahiskali, R; Akalin, S; Budak, Y; Ekicioglu, G; Emerk, K; Ersöz, O; Kuçükkaya, B; Yavuz, DG | 1 |
Yoshikawa, H | 1 |
Kamata, K; Mizutani, K | 1 |
Amiri, F; Garcia, R | 1 |
Katoh, M; Kurosawa, Y; Narita, H; Ohmachi, Y; Tanaka, N; Yoneda, H | 1 |
Arbin, V; Claperon, N; Fournié-Zaluski, MC; Peyroux, J; Roques, BP | 1 |
Kedziora-Kornatowska, KZ; Luciak, M; Paszkowski, J | 1 |
Fukui, M; Shou, I; Tomino, Y | 1 |
Al-Shafei, AI; Bronns, G; Carpenter, TA; Gresham, GA; Hall, LD; Huang, CL; Wise, RG | 1 |
Al-Shafei, AI; Carpenter, TA; Gresham, GA; Hall, LD; Huang, CL; Wise, RG | 1 |
Isogai, S; Mogami, K; Ouchi, H; Yoshino, G | 1 |
Kesavarao, U; Sharma, JN | 1 |
Ha, H; Kim, KH | 1 |
Cho, C; Katz, A; Silverman, M; Whiteside, C | 1 |
Fujishima, M; Iwase, M; Nakao, Y; Sadoshima, S; Takata, Y; Takishita, S; Tomita, Y; Tsuchihashi, T; Yamashita, Y | 1 |
Goldfarb, S; Kern, EF; Simmons, DA; Ziyadeh, FN | 1 |
Reddi, AS | 1 |
Gottardo, G; Malendowicz, LK; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P | 1 |
Belloni, AS; Gottardo, G; Malendowicz, LK; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P | 1 |
Dietze, G; Fink, E; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M | 1 |
Ashford, A; Bailey, GS; Jaffa, AA; Pratt, J | 1 |
Akabane, S; Ito, K; Kawamura, M; Kojima, S; Matsushima, Y | 1 |
Bennett, T; Gardiner, SM; Hebden, RA | 3 |
Ramos, OL | 1 |
2 review(s) available for captopril and Alloxan Diabetes
Article | Year |
---|---|
Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertension; Kidney Glomerulus; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
An impairment of barrier size and charge selectivity of glomerular basement membrane in streptozotocin-induced diabetes and prevention by pharmacological therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anions; Basement Membrane; Captopril; Diabetes Mellitus, Experimental; Kidney Glomerulus; Male; Microscopy, Electron; Rats; Rats, Wistar; Streptozocin | 2000 |
96 other study(ies) available for captopril and Alloxan Diabetes
Article | Year |
---|---|
Captopril alleviates oxidative damage in diabetic retinopathy.
Topics: Animals; Captopril; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Endothelial Cells; Glucose; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retina; Retinal Vessels; Streptozocin; Tyrosine; Vascular Endothelial Growth Factor A | 2022 |
Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33.
Topics: Animals; ATP Binding Cassette Transporter 1; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; MicroRNAs; Rats; Rats, Wistar; Spironolactone | 2022 |
Effect of the renin-angiotensin system on the exacerbation of adrenal glucocorticoid steroidogenesis in diabetic mice: Role of angiotensin-II type 2 receptor.
Topics: Alloxan; Animals; Captopril; Corticosterone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucocorticoids; Mice; Renin-Angiotensin System | 2022 |
Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Urea Nitrogen; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuretics; Drug Combinations; Drug Repositioning; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; MicroRNAs; Rats; Rats, Wistar; Spironolactone; Streptozocin; Transforming Growth Factor beta; Treatment Outcome | 2019 |
Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Azabicyclo Compounds; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Hypertension, Renal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Podocytes; Pyrimidines; Receptors, CCR2 | 2019 |
Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3β, P-GSK3β pathway.
Topics: Amides; Animals; Avoidance Learning; Brain; Captopril; Cholinesterases; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Fumarates; Glycogen Synthase Kinase 3; Hippocampus; Interleukin-1beta; Male; MAP Kinase Signaling System; Maze Learning; Pancreas; Rats; Rats, Sprague-Dawley; Recognition, Psychology | 2020 |
Combination of Captopril with Gliclazide Decreases Vascular and Renal Complications and Improves Glycemic Control in Rats with Streptozotocin- Induced Diabetes Mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Aorta, Thoracic; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Gliclazide; Glycemic Control; Hypoglycemic Agents; Kidney; Male; Rats; Rats, Wistar; Streptozocin | 2021 |
Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats.
Topics: Animals; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Hypoglycemic Agents; Male; Metformin; Rats; Rats, Wistar; RNA, Messenger; Streptozocin | 2020 |
Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds.
Topics: Administration, Cutaneous; Alloxan; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Disease; Diabetes Mellitus, Experimental; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Skin; Swine; Swine, Miniature; Time Factors; Treatment Outcome; Valsartan; Wound Healing; Wounds and Injuries | 2018 |
Captopril inhibits calpain‑mediated apoptosis of myocardial cells in diabetic rats and improves cardiac function.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Calpain; Captopril; Caspase 3; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Heart; Humans; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Ventricular Dysfunction, Left | 2018 |
Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus.
Topics: Animals; Aspirin; Atorvastatin; Captopril; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Metformin; Neuroprotective Agents; Rats; Rats, Wistar; Streptozocin | 2019 |
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation | 2014 |
RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Spironolactone | 2013 |
Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.
Topics: Animals; Blood Pressure; Captopril; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Eye Proteins; Kidney; Macrophages; Male; Membrane Proteins; Mice; Nerve Growth Factors; Serpins | 2015 |
Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Captopril; Creatinine; Curcumin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Kidney; Lipids; Male; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 2015 |
Renal functional responses in diabetic nephropathy following chronic bilateral renal denervation.
Topics: Animals; Blood Pressure; Captopril; Denervation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Heart Rate; Kidney; Natriuretic Agents; Random Allocation; Rats, Transgenic; Renal Circulation; Renin-Angiotensin System; Sympathetic Nervous System | 2017 |
The effects of zofenopril on cardiac function and pro-oxidative parameters in the streptozotocin-induced diabetic rat heart.
Topics: Animals; Biomarkers; Captopril; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Male; Oxidative Stress; Rats; Rats, Wistar | 2017 |
Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone and Bones; Bone Resorption; Calcium; Captopril; Diabetes Mellitus, Experimental; Femur; Fibrosis; Kidney; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Renin-Angiotensin System; RNA, Messenger; Tibia; Vitamin D3 24-Hydroxylase; X-Ray Microtomography | 2017 |
Effect of Picrorrhiza rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Hypoglycemic Agents; Kidney; Organ Size; Phytotherapy; Picrorhiza; Plant Extracts; Rats; Rats, Sprague-Dawley | 2008 |
Ameliorative effect of Captopril and Valsartan on an animal model of diabetic cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Isoenzymes; L-Lactate Dehydrogenase; Male; Microscopy, Electron; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2008 |
Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Nuclear Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 2009 |
Influence of selected angiotensin-converting enzyme inhibitors on alloxan-induced diabetic cataract in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Captopril; Cataract; Diabetes Mellitus, Experimental; Enalapril; Rabbits | 2009 |
Effect of captopril and the bradykinin-PKC pathway on ROS production in type 1 diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Body Weight; Bradykinin; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Insulin; Myocardium; Neutrophils; Oxidative Stress; Protein Kinase C; Rats, Inbred F344; Reactive Oxygen Species; Signal Transduction | 2011 |
Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Apoptosis; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enzyme Inhibitors; Hemodynamics; In Situ Nick-End Labeling; Male; Malondialdehyde; Microscopy, Electron, Transmission; Myocardium; Organ Size; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; Superoxide Dismutase | 2012 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Caspase 3; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fas Ligand Protein; Glutathione; Heme Oxygenase (Decyclizing); Hyperglycemia; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Kidney Diseases; Male; Malondialdehyde; Microtubule-Associated Proteins; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Survivin; Tumor Necrosis Factor-alpha | 2013 |
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Topics: Alanine; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Captopril; Cardiomegaly; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Enzyme Inhibitors; Hypertension; Hypertrophy; Male; Mesenteric Arteries; Neprilysin; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2003 |
Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Kidney; Lipid Peroxidation; Losartan; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Proteins; Rats; Rats, Wistar | 2003 |
Captopril inhibits glucose accumulation in retinal cells in diabetes.
Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Blood Glucose; Blotting, Western; Captopril; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Glucose; Glucose Transporter Type 1; Lisinopril; Male; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels | 2003 |
Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Fluorescein Angiography; Hemodynamics; Male; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Retinal Vessels; Tetrazoles; Vasodilation | 2004 |
A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Chromans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Genes, Reporter; Hypoglycemic Agents; Kidney; Luciferases; Male; Mice; Organ Size; Plasmids; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone; Urodynamics | 2003 |
C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; C-Peptide; Captopril; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2004 |
Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
Topics: Albuminuria; Amlodipine; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Synergism; Fibronectins; Glomerular Filtration Rate; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Verapamil | 2004 |
[Effects of captopril on myocardial tissue energy metabolism and inflammation in rats with diabetic cardiomyopathy].
Topics: Animals; Captopril; Cardiomyopathies; Diabetes Mellitus, Experimental; Energy Metabolism; Male; Myocardium; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley | 2004 |
[The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Mice; Random Allocation; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2004 |
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Glomerulus; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 2005 |
Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
Topics: Administration, Oral; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Benzazepines; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin-Converting Enzymes; Fibrosis; Kidney; Metalloendopeptidases; Neprilysin; Protease Inhibitors; Proteinuria; Rats; Rats, Wistar; Time Factors | 2004 |
Effect of diabetes on aortic nitric oxide synthesis in spontaneously hypertensive rats; does captopril modulate this effect?
Topics: Animals; Aorta; Captopril; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Rats; Rats, Inbred SHR | 2005 |
Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Captopril; Chelating Agents; Diabetes Mellitus, Experimental; Edetic Acid; Male; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Phenanthrolines; Receptor, Angiotensin, Type 1; Renin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2005 |
Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Hypertension; Immunohistochemistry; Kidney Glomerulus; Rats; Rats, Inbred SHR | 2006 |
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
Topics: Angiotensin II; Angiotensinogen; Animals; Anti-Arrhythmia Agents; Buffers; Captopril; Diabetes Complications; Diabetes Mellitus, Experimental; Diffusion; Free Radical Scavengers; Imidazoles; Kallikreins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Perfusion; Rats; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 90-kDa; Species Specificity; Tetrazoles | 2006 |
Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Disease Models, Animal; Glomerular Filtration Rate; Kidney; Male; Natriuresis; Nephrectomy; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sodium; Time Factors | 2006 |
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Hyperglycemia; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Superoxides; Tetrazoles; Vasodilation | 2007 |
Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Captopril; Cell Membrane; Diabetes Mellitus, Experimental; Drug Implants; Gene Expression Regulation; Heart; Insulin; Islets of Langerhans Transplantation; Male; Myocardium; Oligonucleotide Array Sequence Analysis; Peroxisome Proliferator-Activated Receptors; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Inbred Lew; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2007 |
Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Blood Glucose; Captopril; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ginkgo biloba; Kidney; Male; Matrix Metalloproteinase 2; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1 | 2007 |
The effects of captopril and losartan on erythrocyte membrane Na+/K(+)-ATPase activity in experimental diabetes mellitus.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Erythrocyte Membrane; Losartan; Male; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 2007 |
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Capillaries; Captopril; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Hyperglycemia; Leukostasis; Losartan; Male; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Vascular Cell Adhesion Molecule-1 | 2007 |
Gender-specific regulation of pancreatic islet blood flow, insulin levels and glycaemia in spontaneously diabetic Goto-Kakizaki rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Irbesartan; Islets of Langerhans; Male; Pravastatin; Rats; Rats, Mutant Strains; Regional Blood Flow; Sex Factors; Tetrazoles | 2008 |
Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Losartan; Male; Organ Size; Random Allocation; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
Effect of verapamil and captopril on endothelial injury in the diabetic hypertensive rat.
Topics: Animals; Blood Pressure; Blood Vessels; Body Weight; Captopril; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hypertension; Male; Myocardium; Rats; Rats, Wistar; Tunica Media; Verapamil | 1994 |
Effects of somatostatin and captopril on glomerular prostaglandin E2 production in normal and diabetic rats.
Topics: Animals; Captopril; Diabetes Mellitus, Experimental; Dinoprostone; In Vitro Techniques; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Somatostatin | 1993 |
Urinary active kallikrein excretion and diabetic renal impairments in streptozotocin-treated rats.
Topics: Animals; Captopril; Diabetes Mellitus, Experimental; Kallikreins; Kidney; Male; Proteinuria; Rats; Rats, Inbred WKY; Streptozocin | 1993 |
[Effects of captopril on myocardial ultrastructure in diabetic rats].
Topics: Animals; Captopril; Diabetes Mellitus, Experimental; Female; Heart; Insulin; Mitochondria, Heart; Myocardium; Rats; Rats, Sprague-Dawley | 1993 |
Angiotensin-converting enzyme inhibition partially prevents diabetic organomegaly.
Topics: Analysis of Variance; Animals; Captopril; Cardiomegaly; Diabetes Mellitus, Experimental; Female; Fibronectins; Hepatomegaly; Hypertrophy; Kidney; Organ Size; Rats; Rats, Sprague-Dawley | 1994 |
[Renal structure and function in experimental diabetic rats following unilateral nephrectomy].
Topics: Animals; Captopril; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Insulin; Kidney; Male; Nephrectomy; Rats; Rats, Wistar | 1993 |
Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Cholesterol, HDL; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose Tolerance Test; Hypertension; Insulin; Insulin Resistance; Male; Rats; Rats, Inbred SHR; Streptozocin; Triglycerides | 1996 |
Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.
Topics: Animals; Blood Pressure; Captopril; Collagen; Diabetes Mellitus, Experimental; Diastole; Guanidines; Male; Organ Size; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left | 1996 |
Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Enzyme Inhibitors; Isoenzymes; Male; Ouabain; Peptidyl-Dipeptidase A; Random Allocation; Rats; Retina; Sodium-Potassium-Exchanging ATPase; Streptozocin | 1996 |
Effects of benidipine, a calcium antagonist, on urinary kallikrein excretion and renal impairment in experimental diabetes.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Experimental; Dihydropyridines; Kallikreins; Male; Proteinuria; Radioimmunoassay; Rats; Rats, Inbred WKY; Streptozocin | 1996 |
[Effects of insulin and captopril on growth of glomerular mesangial cells in STZ-induced diabetic rats].
Topics: Animals; Captopril; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Glomerular Mesangium; Hypoglycemic Agents; Insulin; Interleukin-6; Male; Rats; Rats, Wistar; Streptozocin; Tumor Necrosis Factor-alpha | 1996 |
Neutral endopeptidase inhibition, a new approach in the exploration of diabetic vasculopathy in rats.
Topics: Alanine; Animals; Blood Pressure; Capillary Permeability; Captopril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Female; Glycopeptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Streptozocin; Thiorphan | 1995 |
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 1997 |
Cardiovascular and renal protective effects of losartan in spontaneously hypertensive rats with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hemodynamics; Hypertension; Imidazoles; Kidney Diseases; Losartan; Male; Nephrectomy; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Glucose; Captopril; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glutathione Peroxidase; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Superoxide Dismutase | 1997 |
Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Insulin; Kidney; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Reference Values; Renin; RNA, Messenger; RNA, Ribosomal, 28S; Transcription, Genetic | 1997 |
Effects of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertrophy; Imidazoles; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred Strains; Pyridines; Receptors, Angiotensin; Streptozocin | 1997 |
Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Guanidines; Hydrochlorothiazide; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Kidney; Kidney Function Tests; Male; Molecular Weight; Pyrazines; Rats; Rats, Sprague-Dawley; Serum Albumin; Streptozocin | 1997 |
Studies on pyrazinoylguanidine. 6. Prevention of cataracts in STZ-diabetic rats.
Topics: Animals; Antihypertensive Agents; Captopril; Cataract; Diabetes Mellitus, Experimental; Guanidines; Hypoglycemic Agents; Male; Odds Ratio; Pyrazines; Rats; Rats, Sprague-Dawley; Streptozocin | 1997 |
Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Eating; Female; Insulin; Insulin-Like Growth Factor I; Kidney; Octreotide; Organ Size; Rats; Rats, Wistar; Streptozocin | 1998 |
Effect of angiotensin convertase inhibitors on lipid peroxidation and peroxyl radical-trapping capacity in rats with experimental diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Enalapril; Erythrocytes; Free Radicals; Lipid Peroxidation; Male; Malondialdehyde; Peroxides; Rats; Rats, Wistar | 1998 |
Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Hypertension; Male; Methionine; Neprilysin; Propionates; Rats; Rats, Inbred SHR; Renal Circulation; Renin; Sulfhydryl Compounds | 1998 |
The effect of losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Animals; Anions; Antihypertensive Agents; Captopril; Cell Membrane; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Mesangium; Glycosaminoglycans; Losartan; Rats; Rats, Wistar; Sialic Acids; Streptozocin | 1999 |
[Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; RNA, Messenger; Thiazepines | 1999 |
Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Drug Interactions; Kidney; Losartan; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renal Artery; Streptozocin; Vasoconstriction | 1999 |
Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin and ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Captopril; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Isoenzymes; Kidney Glomerulus; Male; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 2000 |
Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Imidazolidines; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Renal Artery; Streptozocin | 2000 |
Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Femoral Artery; Hemodynamics; Kininogens; Lysine Carboxypeptidase; Male; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Thiorphan; Time Factors | 2000 |
Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Captopril; Catalase; Diabetes Mellitus, Experimental; Enalapril; Hemoglobin A; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors | 2000 |
Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Peptidyl-Dipeptidase A; Pigment Epithelium of Eye; Rats; Rats, Long-Evans; Retina; Sodium-Potassium-Exchanging ATPase | 2001 |
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Heart; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging, Cine; Male; Myocardium; Organ Size; Rats; Rats, Wistar | 2002 |
Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; Diabetes Mellitus, Experimental; Heart; Magnetic Resonance Imaging, Cine; Male; Myocardial Contraction; Rats; Rats, Wistar; Stroke Volume; Ventricular Function, Left | 2002 |
Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kallikreins; Male; Rats; Rats, Inbred SHR | 2002 |
Amelioration of diabetic microalbuminuria and lipid peroxidation by captopril.
Topics: Albuminuria; Animals; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Insulin; Lipid Peroxidation; Male; Rats; Rats, Sprague-Dawley | 1992 |
Diabetic glomerulopathy following unilateral nephrectomy in the dog.
Topics: Albuminuria; Animals; Anions; Basement Membrane; Capillary Permeability; Captopril; Dextrans; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dogs; Glomerular Filtration Rate; Glomerular Mesangium; Hypertrophy; Indicator Dilution Techniques; Inulin; Kidney; Male; Microscopy, Electron; Nephrectomy; Organ Size; Pancreatectomy; Renin | 1990 |
Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Ganglionic Blockers; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System; Streptozocin | 1990 |
Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diet; Dietary Proteins; Glomerular Filtration Rate; Imidazoles; Imidazolidines; Inositol; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains; Reference Values; Regional Blood Flow; Sugar Alcohols | 1991 |
Prevention of albuminuria by captopril in diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Captopril; Chromatography, Ion Exchange; Diabetes Mellitus, Experimental; Glycosaminoglycans; Heparin; In Vitro Techniques; Kidney Glomerulus; Male; Potassium; Rats; Rats, Inbred Strains; Sulfates; Sulfur Radioisotopes | 1991 |
Streptozotocin-induced experimental diabetes causes a time-dependent inhibition of growth and steroidogenic capacity of rat adrenal zona glomerulosa.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Captopril; Cell Nucleus; Dexamethasone; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Kinetics; Male; Mitochondria; Rats; Rats, Inbred Strains; Zona Glomerulosa | 1990 |
Zona glomerulosa morphology and function in streptozotocin-induced diabetic rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Blood Glucose; Captopril; Dexamethasone; Diabetes Mellitus, Experimental; Endothelium; Male; Microscopy, Electron; Mitochondria; Potassium; Rats; Rats, Inbred Strains; Renin | 1988 |
Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Bradykinin; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Kinins; Male; Metabolic Clearance Rate; Rats; Rats, Inbred Strains | 1986 |
Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Bradykinin; Captopril; Diabetes Mellitus, Experimental; Insulin; Lung; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Swine | 1986 |
Effects of captopril and nicardipine on renal hyperfiltration and hypertrophy in uninephrectomized diabetic rats.
Topics: Animals; Captopril; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Hypertrophy; Kidney; Male; Nephrectomy; Nicardipine; Rats; Rats, Inbred Strains | 1988 |
Blood pressure recovery following haemorrhage in rats with streptozotocin-induced diabetes mellitus.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Heart Rate; Hemorrhage; Hypotension; Male; Rats; Rats, Inbred Strains | 1988 |
Diabetes mellitus and hypertension. State of the art lecture.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Hypertension; Hypertension, Renovascular; Kidney; Norepinephrine; Prazosin; Rats; Time Factors; Vasopressins | 1988 |
Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Captopril; Diabetes Mellitus, Experimental; Heart Rate; Male; Methoxamine; Pentolinium Tartrate; Pressoreceptors; Rats; Rats, Inbred Strains; Renin; Vasopressins | 1987 |
Abnormal blood pressure recovery during ganglion blockade in diabetic rats.
Topics: Animals; Blood Pressure; Captopril; Deamino Arginine Vasopressin; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Heart Rate; Insulin; Male; Pentolinium Tartrate; Rats; Rats, Inbred Strains | 1987 |